Latest Articles

Publication Date
Progestagens for pain symptoms associated with endometriosis.

Endometriosis is a hormone-sensitive inflammatory condition affecting between 5% and 10% of reproductive-aged women and an unknown number of gender-diverse individuals. It is often associated with debilitating pelvic pain symptoms. …

Published: Oct. 9, 2025, midnight
A Systematic Review of the Prevalence of Endometriosis in Trans Men.

This systematic review aims to synthesize available evidence on the prevalence of endometriosis in the trans male population.

Published: Oct. 6, 2025, midnight
Performing Endometriosis as placental dramaturgy.

Performing Endometriosis is an autopathographic piece, written and performed by VR and directed by MM (coauthors of the present article). Divided into very short scenes (called Glimpses), Performing Endometriosis is …

Published: Oct. 1, 2025, midnight
TVO Podcast ‘(MIS)Treated’ Examines Canada’s Gender Gap in Healthcare - The Malaysian Reserve

TVO Podcast ‘(MIS)Treated’ Examines Canada’s Gender Gap in Healthcare The Malaysian Reserve

Published: Sept. 25, 2025, 8:18 p.m.
TVO Podcast ‘(MIS)Treated’ Examines Canada’s Gender Gap in Healthcare - TVO Media Education Group

TVO Podcast ‘(MIS)Treated’ Examines Canada’s Gender Gap in Healthcare TVO Media Education Group

Published: Sept. 25, 2025, 3:11 p.m.
Insights from focus groups with trans and gender-diverse people with endometriosis: stories you tell, stories you don't.

Endometriosis is a chronic condition characterised by cyclic pain symptoms that often significantly affect health-related quality of life. Predominantly framed as a "woman's condition," current research overlooks the experiences of …

Published: Sept. 17, 2025, midnight
Trusting women’s intuition: How technology can narrow the gender health gap - Forbes Australia

Trusting women’s intuition: How technology can narrow the gender health gap Forbes Australia

Published: Sept. 8, 2025, 11:46 p.m.
Triptorelin associated adverse events evaluated using FAERS pharmacovigilance data.

Triptorelin, a gonadotropin-releasing hormone(GnRH) agonist, is approved by the US Food and Drug Administration(FDA) for treating advanced prostate cancer, endometriosis, and central precocious puberty(CPP) in children aged ≥ 2 years. …

Published: Sept. 1, 2025, midnight
Gender-Specific Healthcare Innovations: A Dual-Track Investment in Longevity and Economic Growth - AInvest

Gender-Specific Healthcare Innovations: A Dual-Track Investment in Longevity and Economic Growth AInvest

Published: Aug. 30, 2025, 2:41 a.m.
Endometriosis among Transgender and Gender Diverse Patients Imaging Study (ETRIS).

to assess the prevalence of surgically confirmed endometriosis among assigned-female-at-birth (AFAB) transgender and gender diverse (TGD) individuals undergoing laparoscopic pelvic surgery.

Published: Aug. 28, 2025, midnight
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!